Purple Is The New Orange: A New Book On Biosimilars
On Sept. 9, 2014, the U.S. Food and Drug Administration published the first edition of the Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability...To view the full article, register now.
Already a subscriber? Click here to view full article